TNDM
TANDEM DIABETES CARE INC
NASDAQ · Healthcare · Medical - Devices · US
$19.11
−3.44%Oct 1, 2026, 20:05 UTC
Tandem Diabetes Care announced it will release its third quarter 2026 financial results on November 5, 2026, with a conference call and webcast the same day.
Source:Sep 28, 2026, 07:00 UTC
Tandem Diabetes Care made its Tandem Mobi automated insulin delivery system, featuring Control-IQ+ technology, available in twelve international markets.
Source:Aug 6, 2026, 20:05 UTC
Tandem Diabetes Care reported its financial results for the quarter ended June 30, 2026, with worldwide sales of $254.6 million and gross margin of 57%.
Jul 1, 2026, 12:30 UTC
Tandem Diabetes Care launched t:slim X2 insulin pump compatibility with Abbott FreeStyle Libre 3 Plus sensor in five EU countries.
Source:Jun 5, 2026, 12:30 UTC
Tandem Diabetes Care received CE mark approval for its automated insulin delivery systems for use in type 1 diabetes during pregnancy and adults with type 2 diabetes in Europe.
Source: